Key Findings:  The synthetic pharmaceutical cannabinoid or THC analogue i.e. nabilone significantly reduces levodopa-induced dyskinesia in patients with Parkinson's Disease.
Type of Study:  Double Blind Clinical Trial
Study Sample Size:  7
Study Result:  Positive
Research Location(s):  United Kingdom
Year of Pub:  2001
Cannabinoids Studied:  Pharma THC
Phytocannabinoid Source:  Not Applicable
Chemotype:  Chemotype I
Sub-Ratio: 1:0
Route of Administration:  Oral (Ingestion)
Citation:  Sieradzan KA, et al. Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology. 2001; 57:2108-11. doi: 10.1212/wnl.57.11.2108
Authors:  Sieradzan KA, Fox SH, Hill M, Dick JP, Crossman AR, Brotchie JM